Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.

Yeung A, Bhargava RK, Ahn R, Bahna S, Kang NH, Lacoul A, Niles LP.

Biomed Pharmacother. 2012 Apr;66(3):232-6. doi: 10.1016/j.biopha.2011.06.007. Epub 2011 Aug 27.

PMID:
22436652
2.

Suberoyl bis-hydroxamic acid induces p53-dependent apoptosis of MCF-7 breast cancer cells.

Zhuang ZG, Fei F, Chen Y, Jin W.

Acta Pharmacol Sin. 2008 Dec;29(12):1459-66. doi: 10.1111/j.1745-7254.2008.00906.x.

3.

P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.

Bajbouj K, Mawrin C, Hartig R, Schulze-Luehrmann J, Wilisch-Neumann A, Roessner A, Schneider-Stock R.

J Neurooncol. 2012 May;107(3):503-16. doi: 10.1007/s11060-011-0791-2. Epub 2012 Jan 20.

PMID:
22270849
4.

Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.

Knutson AK, Welsh J, Taylor T, Roy S, Wang WL, Tenniswood M.

Oncol Rep. 2012 Mar;27(3):849-53. doi: 10.3892/or.2011.1590. Epub 2011 Dec 12.

PMID:
22159450
5.
6.

Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.

Condorelli F, Gnemmi I, Vallario A, Genazzani AA, Canonico PL.

Br J Pharmacol. 2008 Feb;153(4):657-68. Epub 2007 Dec 3.

7.

Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.

Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.

Int J Mol Med. 2008 Nov;22(5):605-11.

PMID:
18949380
8.

The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.

Meng J, Zhang HH, Zhou CX, Li C, Zhang F, Mei QB.

Oncol Rep. 2012 Jul;28(1):384-8. doi: 10.3892/or.2012.1793. Epub 2012 Apr 30.

PMID:
22552631
9.

Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells.

Wang J, Kim TH, Ahn MY, Lee J, Jung JH, Choi WS, Lee BM, Yoon KS, Yoon S, Kim HS.

Int J Oncol. 2012 Sep;41(3):1101-9. doi: 10.3892/ijo.2012.1534. Epub 2012 Jun 26.

PMID:
22751989
12.

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2390-8.

PMID:
12766035
13.

Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.

Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD.

FASEB J. 2002 Sep;16(11):1447-9. Epub 2002 Jul 18.

PMID:
12205043
14.

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.

Takai N, Desmond JC, Kumagai T, Gui D, Said JW, Whittaker S, Miyakawa I, Koeffler HP.

Clin Cancer Res. 2004 Feb 1;10(3):1141-9.

15.

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.

Thiantanawat A, Long BJ, Brodie AM.

Cancer Res. 2003 Nov 15;63(22):8037-50.

16.

Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro?

Cos S, Mediavilla MD, Fernández R, González-Lamuño D, Sánchez-Barceló EJ.

J Pineal Res. 2002 Mar;32(2):90-6.

PMID:
12071473
17.

A novel gamma-lactam-based histone deacetylase inhibitor potently inhibits the growth of human breast and renal cancer cells.

Kwon HK, Ahn SH, Park SH, Park JH, Park JW, Kim HM, Park SK, Lee K, Lee CW, Choi E, Han G, Han JW.

Biol Pharm Bull. 2009 Oct;32(10):1723-7.

19.

Supplemental Content

Support Center